Rapport Therapeutics, Inc.

Rapport Therapeutics, Inc. financial statements

Rapport Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 111.48M10-K
Cash and equivalentsUSD 52.65M10-Q
Total debtUSD 11.48MEODHD

Rapport Therapeutics, Inc. financials on 6ix · Rapport Therapeutics, Inc. on 6ix